National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management

National Institute for Health and Care Excellence (NICE) Guidelines on Cannabis-Based Medicinal Products: Clinical Practice Implications for Epilepsy Management

The UK’s National Institute for Health and Care Excellence (NICE) has produced new evidence-based guidance on the prescription of cannabis-based medicinal products (CBMP) to treat epilepsy, chronic pain, spasticity, and intractable nausea and vomiting. For epilepsy, cannabidiol (CBD) (Epidyolex®, GW...

Full description

Bibliographic Details
Main Authors: Rhys H. Thomas, Jacob Brolly
Format: Article
Language:English
Published: European Medical Journal 2020-06-01
Series:European Medical Journal
Subjects:
cannabidiol (cbd)
epilepsy
national institute for health and care excellence (nice)
Online Access:https://www.emjreviews.com/neurology/article/national-institute-for-health-and-care-excellence-nice-guidelines-on-cannabis-based-medicinal-products-clinical-practice-implications-for-epilepsy-management/

Internet

https://www.emjreviews.com/neurology/article/national-institute-for-health-and-care-excellence-nice-guidelines-on-cannabis-based-medicinal-products-clinical-practice-implications-for-epilepsy-management/

Similar Items